SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-003114
Filing Date
2021-11-04
Accepted
2021-11-04 16:58:23
Documents
12
Period of Report
2021-10-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K sqz-20211029.htm   iXBRL 8-K 51113
  Complete submission text file 0000950170-21-003114.txt   172174

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sqz-20211029_pre.xml EX-101.PRE 10225
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sqz-20211029.xsd EX-101.SCH 2478
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sqz-20211029_lab.xml EX-101.LAB 13896
5 EXTRACTED XBRL INSTANCE DOCUMENT sqz-20211029_htm.xml XML 4890
Mailing Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472 617-898-8824
SQZ Biotechnologies Co (Filer) CIK: 0001604477 (see all company filings)

IRS No.: 462431115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39662 | Film No.: 211380918
SIC: 2836 Biological Products, (No Diagnostic Substances)